Quick Overview: We had our 17th interivew of the channel with Prof. Our Website: Subscribe and review our Podcast on iTunes: On Thursday, April 29, newly appointed director of the MIT's Koch Institute for Integrative Cancer Research

Matthew G Vander Heiden Md - Detailed Overview & Context

We had our 17th interivew of the channel with Prof. Our Website: Subscribe and review our Podcast on iTunes: On Thursday, April 29, newly appointed director of the MIT's Koch Institute for Integrative Cancer Research At "The Patient is In," KI faculty member "Using Stable Isotopes to Study Proliferating Cell Metabolism" Thinking differently: making the improbable possible in a new era Presented by

In the third episode of the "Let's Get to Know... Celebrating Diversity at MIT" podcast, we have a conversation with our ... SU2C's Innovative Research Grants (IRGs) support cutting-edge cancer research that might not receive funding through ... ... 24:07 Daniela Quail, McGill University 40:08 ... Biochemistry, Spring 2020 Instructor: To get a sense of where these discussions may take cancer physicians and scientists, we reached out to At the special "The Patient is In" event on November 21, KI faculty member

Photo Gallery

Interview on cancer with Prof. Dr. Matthew G. Vander Heiden, Koch Institute, MIT
Matthew G. Vander Heiden, MD, PhD, a Damon Runyon Scientist
InDepth Examination of Cancer Cells and Cell Metabolism Impact Factors with Matthew G. Vander Heiden
A Conversation with the New Director
Technology Day 2021: Pathways to the Future of Cancer Research
The Patient is In: Q&A
Isotope Day 2021-Mass Spectrometry (MS) with Matthew Vander Heiden, MD, PhD
Thinking differently: making the improbable possible in a new era
Episode 3: "Let's Get to Know... Celebrating Diversity at MIT", feat. Prof. Dr. Matt Vander Heiden
Inside the Lab: Matthew Vander Heiden, M.D., Ph.D.
Meet an IRG Recipient: Matthew Vander Heiden
Meet the new MIT Koch Institute director, Matthew Vander Heiden
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored